Medicon Hellas S.A.

ATSE:MEDIC Voorraadrapport

Marktkapitalisatie: €10.2m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Medicon Hellas Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Dimotsantos Spyridon

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO3.3yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur3.3yrs

Recente managementupdates

Recent updates

Medicon Hellas (ATH:MEDIC) Has Announced That It Will Be Increasing Its Dividend To €0.06

Jul 11
Medicon Hellas (ATH:MEDIC) Has Announced That It Will Be Increasing Its Dividend To €0.06

Medicon Hellas (ATH:MEDIC) Is Reinvesting At Lower Rates Of Return

Aug 04
Medicon Hellas (ATH:MEDIC) Is Reinvesting At Lower Rates Of Return

There Are Reasons To Feel Uneasy About Medicon Hellas' (ATH:MEDIC) Returns On Capital

Feb 18
There Are Reasons To Feel Uneasy About Medicon Hellas' (ATH:MEDIC) Returns On Capital

Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital

Jun 10
Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital

Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)

Apr 30
Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)

Investors Could Be Concerned With Medicon Hellas' (ATH:MEDIC) Returns On Capital

Sep 30
Investors Could Be Concerned With Medicon Hellas' (ATH:MEDIC) Returns On Capital

Medicon Hellas (ATH:MEDIC) Could Easily Take On More Debt

Jun 07
Medicon Hellas (ATH:MEDIC) Could Easily Take On More Debt

Based On Its ROE, Is Medicon Hellas S.A. (ATH:MEDIC) A High Quality Stock?

Feb 25
Based On Its ROE, Is Medicon Hellas S.A. (ATH:MEDIC) A High Quality Stock?

The Returns At Medicon Hellas (ATH:MEDIC) Provide Us With Signs Of What's To Come

Nov 23
The Returns At Medicon Hellas (ATH:MEDIC) Provide Us With Signs Of What's To Come

CEO

Dimotsantos Spyridon (77 yo)

3.3yrs

Tenure

Mr. Dimotsantos S. Spyridon is CEO & Chairman of the Board of Medicon Hellas S.A. from June 30, 2021. He serves as a Chief Executive Officer of Medicon Hellas S.A.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Dimotsantos Spyridon
CEO & Chairman of the Board3.3yrsgeen gegevensgeen gegevens
Georgios Dimotsantos
Deputy CEO & Executive Director10.6yrsgeen gegevensgeen gegevens
Dimitrios Kapetanakis
Independent Non Executive Director3.3yrsgeen gegevensgeen gegevens
Spyridoula Ktisti
Independent Non-Executive Director3.3yrsgeen gegevensgeen gegevens
Vassilios Loumiotis
Independent Non-Executive Director3.3yrsgeen gegevensgeen gegevens
Efstratios Tserkezos
Independent Non-Executive Director3.3yrsgeen gegevensgeen gegevens

3.3yrs

Gemiddelde duur

59.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MEDIC wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).